References
- Burdach S, Jurgern H, Peters C, et al. Myeloablative radio-chemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993; 11: 1482–1488
- Matthay K K, O'Leary M C, Ramsay N K, et al. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results. Eur J Cancer 1995; 31A: 572–575
- Deeg H J, Sullivan K M, Buckner C D, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151–157
- Clift R, Buckner C D, Bianco J, et al. Marrow transplantation in patients with acute myeloid leukemia. Leukemia 1992; 6(Suppl 2)104–109
- Clift R A, Buckner C D, Appelbaum F R, et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660–1665
- Girinsky T, Socie G, Ammarguellat H, et al. Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study of 85 patients. Int J Radiat Oncol Biol Phys 1994; 30: 821–824
- Shank B, Chu F CH, Dinsmore R, et al. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 1983; 9: 1607–1611